The "Europe Radiotherapy Market" has accounted for USD 1.6 billion in 2016, and is expected to reach USD 2.7 billion by 2024, growing at a CAGR 6.7% during the forecast period 2017 to 2024.
Europe Radiotherapy Market, By Therapy (Beam Radiotherapy (IGRT, IMRT, VMAT, Tomotherapy, 3D CRT, Proton Beam, Stereotactic), Brachytherapy (LDR, HDR), Systemic Radiotherapy), By Product Type (Cyberknife, Gammaknife, Linac, Proton Beam, Systemic Radiotherapy, Seeds, Afterloaders), By Indication (Prostate & Breast Cancer)), By Country (Germany, France, U.K., Spain, Italy, Russia, Netherlands, Turkey, Belgium, Switzerland, Rest of Europe) – Industry Trends and Forecast to 2024
Request for Report @ databridgemarketresearch.com/reque…diotherapy-market
Based on geography the Europe Radiotherapy Market is segmented into:
- Rest of Europe
Germany is expected to dominate the Europe radiotherapy market.
There has been rapid development in the radiosurgery field in recent years, owing to increased threat of multiple cancers and mortality. This has allowed pulling in large government and healthcare manufacturers funding’s in research labs developing treatment and preventive techniques against cancer.
The Elekta gamma knife has completed more than 1 million surgeries as announced by Elekta in May 2016.
This shows the demand of radiotherapy products, and the requirement of disruptive technologies to change to modern day radiotherapy.
Inquiry for TOC Visit @ databridgemarketresearch.com/toc/?…diotherapy-market
Some of the major companies operating in this Europe Radiotherapy Market are:
- Varian Medical Systems, Inc.
- CIVCO Medical Solutions
- Elekta AB
- Accuray Incorporated
- Brainlab AG
- Ion Beam Applications SA
- C. R. Bard, Inc.
- IsoRay Medical, Inc.
- Nordion, Inc.
- RaySearch Laboratories AB
- PRECISIS AG
- Mevion Medical Systems, Inc.
- Mitsubishi Electric Corporation among other player
The Europe radiotherapy market is segmented based on therapy, product, application and geography. Based on the therapy, the radiotherapy market is segmented into external beam radiotherapy, internal beam radiotherapy, and systemic radiation therapy.
On the basis of radiations delivered, the external beam radiotherapy is sub segmented into intensity-modulated radiation therapy (IMRT), image guided radiotherapy (IGRT), tomotherapy, stereotactic technology, 3D conformal radiotherapy, proton beam therapy, and volumetric modulated arc therapy (VMAT). The IGRT segment is expected to account for the largest share of the external beam radiotherapy market, whereas the VMAT segment is poised to witness the highest growth.
Based on the delivery of dose-rate, the internal beam therapy is divided into low (LDR) and high-dose rate (HDR).
Based on product type the Europe radiotherapy market is segmented into EBRT equipment’s, and IBRT equipment’s. The External Beam Radiotherapy (EBRT) products are further segmented into cyberknife, gammaknife, LINAC, Proton Beam (Cyclotron, Synclotron).
The Internal Beam Radiotherapy (IBRT) is segmented into seeds, afterloaders and others.
The Europe radiotherapy market is also segmented based on indication into cancer of different organs such as brain tumor, spine cancer, lung cancer, liver cancer, breast cancer, prostate cancer and others.
Browse Full Report Visit @ databridgemarketresearch.com/repor…iotherapy-market/
Category: Market Research Publishers and RetailersCompany about: Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data bridge is an aftermath of sheer wi ...
For more information: